Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus
Leveraging adaptive clinical trial designs in oncology can accelerate drug development, while following the FDA…
CertaraJanuary 16, 2026
Strategic Project Management for Accelerated Drug Development
Expert project leadership to keep complex programs on track, aligned, and moving forward—so you can…
CertaraDecember 23, 2025
A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection
This study synthesizes data from a large body of clinical trials to evaluate rates of…
CertaraDecember 18, 2025
Merck Advances Pediatric Oncology with Innovative ADC Modeling
Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…
CertaraDecember 12, 2025
Expedited Pharmacometrics Regulatory Submissions
Certara delivers complete, compliant pharmacometric regulatory submission packages in just 4–6 weeks, eliminating the PMx…
CertaraDecember 8, 2025
Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings
Certara launches an expedited Pharmacometrics (PMx) Regulatory Submission service that cuts submission timelines in half.
CertaraDecember 3, 2025
